Catalent is a global leader in clinical supply services with flexible solutions for small molecules, biologics, and cell and gene therapies, including integrated services to accelerate products to the clinic.
Catalent has more than 25 years’ experience as a global leader in clinical supply services with flexible solutions for small molecules, biologics, and cell and gene therapies, including integrated services to accelerate products from early development to clinic.
Catalent offers customers a full range of services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage, and global distribution, as well as specialised supply chain services including FlexDirect® direct-to-patient services and FastChain® demand-led supply.
With its eight GMP clinical packaging facilities, as well as two more opening soon, and over 50 strategically located global depots providing local and regional options for storage, distribution, and clinical returns management, Catalent has supported thousands of studies of all sizes and complexities in more than 80 countries.
To accommodate the need for greater flexibility in clinical trials, Catalent offers FlexDirect direct-to-patient supply solutions, enabling clinical supplies to be sent directly to patients’ homes. By reducing or eliminating the need for in-person clinical site visits and removing a key barrier for trial participation, sponsors can expand their geographic recruitment area, especially for rare diseases, potentially improving patient recruitment and retention.
To find out more about Catalent’s integrated services, visit https://www.clinical.catalent.com/